S&P 500 Futures
(-0.05%) 5 211.25 points
Dow Jones Futures
(-0.05%) 39 008 points
Nasdaq Futures
(-0.06%) 18 188 points
Oil
(-0.51%) $77.98
Gas
(0.14%) $2.21
Gold
(0.15%) $2 327.70
Silver
(0.31%) $27.63
Platinum
(0.03%) $988.70
USD/EUR
(0.18%) $0.931
USD/NOK
(0.50%) $10.95
USD/GBP
(0.17%) $0.801
USD/RUB
(0.01%) $91.45

リアルタイムの更新: Lyka Labs Limited [LYKALABS.NS]

取引所: NSE セクター: Healthcare 産業: Biotechnology
最終更新日時8 5月 2024 @ 14:09

1.45% INR 118.30

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 14:09):

Lyka Labs Limited, a pharmaceutical company, engages in development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India...

Stats
本日の出来高 10 471.00
平均出来高 101 780
時価総額 3.91B
EPS INR0 ( 2024-02-08 )
次の収益日 ( INR0 ) 2024-05-20
Last Dividend INR2.50 ( 1996-08-12 )
Next Dividend INR0 ( N/A )
P/E -96.18
ATR14 INR0.344 (0.29%)

ボリューム 相関

長: 0.05 (neutral)
短: 0.47 (neutral)
Signal:(50.076) Neutral

Lyka Labs Limited 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Lyka Labs Limited 相関 - 通貨/商品

The country flag -0.61
( weak negative )
The country flag -0.48
( neutral )
The country flag 0.00
( neutral )
The country flag -0.54
( weak negative )
The country flag -0.33
( neutral )
The country flag 0.20
( neutral )

Lyka Labs Limited 財務諸表

Annual 2022
収益: INR930.73M
総利益: INR555.18M (59.65 %)
EPS: INR-4.57
FY 2022
収益: INR930.73M
総利益: INR555.18M (59.65 %)
EPS: INR-4.57
FY 2022
収益: INR1.84B
総利益: INR1.30B (70.97 %)
EPS: INR13.57
FY 2021
収益: INR671.07M
総利益: INR291.40M (43.42 %)
EPS: INR-4.07

Financial Reports:

No articles found.

Lyka Labs Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Lyka Labs Limited Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 2.22 - No dividend growth expected in the near future
Information
First Dividend INR2.50 1995-09-11
Last Dividend INR2.50 1996-08-12
Next Dividend INR0 N/A
Payout Date 1996-10-01
Next Payout Date N/A
# dividends 2 --
Total Paid Out INR5.00 --
Avg. Dividend % Per Year 0.00% --
Score 0.84 --
Div. Sustainability Score 0
Div.Growth Potential Score 2.22
Div. Directional Score 1.072 --
Next Divdend (Est)
(2024-07-22)
INR0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.84
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
1995 INR0 0.00%
1996 INR0 0.00%
1997 INR0 0.00%
1998 INR0 0.00%
1999 INR0 0.00%
2000 INR0 0.00%
2001 INR0 0.00%
2002 INR0 0.00%
2003 INR0 0.00%
2004 INR0 0.00%
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR0 0.00%
2019 INR0 0.00%
2020 INR0 0.00%
2021 INR0 0.00%
2022 INR0 0.00%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
STARPAPER.NS Dividend Junior 2023-09-15 Sporadic 22 1.19%
MUNJALAU.NS Dividend Junior 2023-08-24 Sporadic 19 1.47%
HINDCOMPOS.NS Dividend Junior 2023-09-22 Annually 23 0.50%
BODALCHEM.NS Dividend Junior 2023-09-22 Annually 14 0.38%
RELAXO.NS Dividend Junior 2023-08-17 Annually 14 0.17%
KRBL.NS Dividend Junior 2023-08-25 Annually 23 0.61%
FCL.NS Dividend Junior 2023-09-08 Annually 10 0.22%
ANANTRAJ.NS Dividend Junior 2023-06-27 Annually 18 0.22%
TATACOFFEE.NS Dividend Junior 2023-05-15 Annually 23 0.85%
NIACL.NS No Dividend Player 2023-09-07 Sporadic 7 0.44%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.03361.500-0.672-1.007[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM-0.1251.500-2.50-3.75[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM0.7351.000-0.839-0.839[3 - 30]
operatingCashFlowPerShareTTM8.012.007.3310.00[0 - 30]
freeCashFlowPerShareTTM8.012.006.0010.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.6141.0003.113.11[0.2 - 0.8]
operatingProfitMarginTTM0.04641.000-1.072-1.072[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score-0.0770

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-110.661.000-10.000[1 - 100]
returnOnEquityTTM-0.1252.50-1.606-3.75[0.1 - 1.5]
freeCashFlowPerShareTTM8.012.007.3310.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM8.012.007.3310.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.8281.5007.810[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2511.0006.230[0.1 - 0.5]
Total Score2.22

Lyka Labs Limited

Lyka Labs Limited, a pharmaceutical company, engages in development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, muscle relaxant, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia, as well as deals in pharmaceutical products. The company offers its products in various formulations, including injections, creams, ointments, gels, and lotions. It also exports its products to Bangladesh, Combodia, Congo, Costa Rica, Peru, Romania, Russia, Sri Lanka, Sudan, Ukraine, Venezuela, and Vietnam. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。